A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1999
10/21/1999	WO1999052520A1 Ionic aqueous composition containing levomenthol
10/21/1999	WO1999052517A2 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps
10/21/1999	WO1999052513A1 Method of manufacturing transdermal patches
10/21/1999	WO1999052512A1 Coated starch capsules and a process for producing them
10/21/1999	WO1999052511A1 Tarch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
10/21/1999	WO1999052510A1 Wettable microcapsules having hydrophobic polymer coated cores
10/21/1999	WO1999052507A1 Incorporation of active substances in carrier matrixes
10/21/1999	WO1999052506A1 Particulate active agent support for pulmonary application
10/21/1999	WO1999052505A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/21/1999	WO1999052504A1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
10/21/1999	WO1999052503A2 Rna cancer vaccine and methods for its use
10/21/1999	WO1999052495A1 External preparations for treating dry skin
10/21/1999	WO1999052463A1 Needleless administration of polynucleotide formulations
10/21/1999	WO1999046245A3 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
10/21/1999	WO1999044573B1 Composition and means for treating dry mouth
10/21/1999	WO1999040113A9 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
10/21/1999	WO1999033454A3 S-procyclidine for treating urinary incontinence
10/21/1999	WO1995026768A9 Methods for treating pulmonary vasoconstriction and asthma
10/21/1999	DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/21/1999	DE19848597A1 Stabilized compositions useful for stimulating collagen neogenesis in treatment of bone defects
10/21/1999	DE19816665A1 Glycolipid-Cremes Glycolipid creams
10/21/1999	CA2340340A1 Particulate excipients for pulmonary administration
10/21/1999	CA2339928A1 Method of manufacturing transdermal patches
10/21/1999	CA2328465A1 Glycolipid creams
10/21/1999	CA2328180A1 Needleless administration of polynucleotide formulations
10/21/1999	CA2328075A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999	CA2327883A1 Slow-release tablet prepared from linear water-insoluble polysaccharides
10/21/1999	CA2327882A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999	CA2327816A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/21/1999	CA2326349A1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
10/21/1999	CA2324364A1 Starch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
10/21/1999	CA2324363A1 Coated starch capsules and a process for producing them
10/21/1999	CA2293605A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
10/20/1999	EP0950419A1 A solid preparation and a method of manufacturing it
10/20/1999	EP0950408A1 Oily patches for external use containing diclofenac sodium
10/20/1999	EP0950404A2 Process for preparation of solid dosage forms
10/20/1999	EP0950403A2 Emulsions for in-situ delivery systems
10/20/1999	EP0950402A2 Chewable pharmaceutical composition with gelatin matrix
10/20/1999	EP0950401A2 Cosmetic and/or pharmaceutical W/O emulsions comprising an alpha-omega oxyalkylated substituted silicone
10/20/1999	EP0950357A1 A toxin decontaminant food product and method of forming same
10/20/1999	EP0950051A1 Micro-particulate form of a tetrahydropyridin derivative
10/20/1999	EP0950012A1 Package of sheet-type patches
10/20/1999	EP0949933A1 Use of cyanoacrylate adhesives for providing a protective barrier film for the skin
10/20/1999	EP0949932A1 Use of hollow microcapsules in diagnosis and therapy
10/20/1999	EP0949929A1 Use of plant extract for inhibition of haemophilus influenzae
10/20/1999	EP0949925A2 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
10/20/1999	EP0949923A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
10/20/1999	EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999	EP0949913A1 Dressing containing essential oils
10/20/1999	EP0949912A1 Method for preparing a multi-particulate pharmaceutical form with controlled multi-sequential release
10/20/1999	EP0949911A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer
10/20/1999	EP0949909A1 Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
10/20/1999	EP0949908A1 Preparation consisting of a surface-adhering, film-like or wafer-like administration form
10/20/1999	EP0949907A1 Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
10/20/1999	EP0949906A1 Compound-loaded liposomes and methods for their preparation
10/20/1999	EP0949905A2 Injectable depot gel composition and method of preparing the composition
10/20/1999	EP0949904A1 Pharmaceutical compositions
10/20/1999	EP0949890A1 Nicotine metabolites, nicotine dependence and human body weight
10/20/1999	EP0949863A2 Skin product having continuing antimicrobial, antiviral, antiseptic, and healing properties
10/20/1999	EP0831867A4 Collagen-based delivery matrix
10/20/1999	EP0767660B1 Methods and formulations for modulating the human sexual response
10/20/1999	EP0767659B1 Transdermal administration of oxybutynin
10/20/1999	EP0673250B1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis
10/20/1999	CN1232411A Microencapsulation process using supercritical fluids
10/20/1999	CN1232394A Solid oral dosage forms of valsartan
10/20/1999	CN1232391A Pharmaceutical microspheres of valproic acid for oral administration
10/20/1999	CN1232389A Patch
10/20/1999	CN1232387A Galenic formula with extended release of milnacipran
10/20/1999	CN1232386A Colonic delivery of weak acid drugs
10/20/1999	CN1231922A Medicine for treatment of cancer
10/20/1999	CN1231916A Hepatitis restoration pill
10/20/1999	CN1231906A Method and special microwave apparatus for preparing instant traditional Chinese medicine in pieces
10/20/1999	CN1231899A Medicinal patch for treatment of cough and asthma
10/20/1999	CN1231898A Easy-to-store and -use compound royal jelly and its preparing method
10/20/1999	CN1231897A Liquid medicine for treatment of bromidrosis, and its preparing method
10/20/1999	CN1231896A Specific treatment of common cold, virus flu, and others against cause of diseases
10/20/1999	CN1231888A Medicine contg. fabric bandage
10/20/1999	CN1231887A Dividable tablet and press-through pack
10/20/1999	CN1045721C Antidiarrheal plaster for infantile diarrhea and its preparing method
10/20/1999	CN1045720C Injection prepared with Taihe chicken bile for treating cataract
10/19/1999	US5969181 Preparation of salts of pharmaceutical active substances which have acidic groups
10/19/1999	US5969020 Uniform matrix containing dispersion of crystalline additive in crystalline thermoplastic resin formed by melting, then solidification and solvent extraction of additive, for drug delivery or medical equipment, bioabsorbable
10/19/1999	US5968987 In lipid-based formulations for oral and injectable use
10/19/1999	US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease
10/19/1999	US5968943 Derivatives of camptothecin and methods of treating cancer using these derivatives
10/19/1999	US5968925 Mixing individual powder components, introducing into extruder, conveying with screw, heating extruder and/or screw so components soften or melt and sinter together, optionally sieving granules
10/19/1999	US5968919 Hormone replacement therapy drug formulations for topical application to the skin
10/19/1999	US5968913 Pharmaceutical compositions of uridine triphosphate
10/19/1999	US5968906 Sucralfate preparations
10/19/1999	US5968895 Solid ionic complexes of luteinizing hormone releasing hormone analogues(active peptides) and anionic polymer carriers, also for stable suspensions or dispersions(not microencapsulated), for treatment of prostate cancer
10/19/1999	US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999	US5968794 Cross-linked polysaccharide or oligosaccharide matrix having grafted, uniformly distributed ionic ligands; particle sizes range from 10 nanometers to 10 micrometers; for encapsulation of active materials
10/19/1999	US5968726 Blood substitute of aqueous solution of hydroxyethyl starch, simple sugar, dynamic buffer, sodium ions, chloride ions, magnesium ions, potassium ions, and calcium ions; with subphysiological concentrations of potassium; autoclavable
10/19/1999	US5968633 Selectively-activatible sheet material for dispensing and dispersing a substance onto a target surface
10/19/1999	US5968554 Drug delivery with core and protective coating
10/19/1999	US5968553 Storage stability, shelf life
10/19/1999	US5968552 Oral drug as antagonist for cardiovascular disorders for time release agents
10/19/1999	US5968551 Sustained release analgesics; bioavailibility
10/19/1999	US5968550 Liquisolid systems and methods of preparing same
10/19/1999	US5968549 Solubilisation aids

1 ... 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 ... 2991